Rebecca A. Greene, PharmD, BCCCP is a clinical pharmacist specialist in critical care. Dr. Greene maintains an active critical care practice in an 18-bed medical ICU, serves as the pharmacy liaison for the Pulmonary Hypertension Service, holds several adjunct faculty appointments, conducts research, and works closely with the division of pulmonary/critical care.
Dr. Greene is a preceptor for the PGY-1 pharmacy practice residency, LAPPE program, and precepts and directs the critical care PGY-2 at Rhode Island Hospital.
Education: Massachusetts College of Pharmacy and Health Sciences, Boston
Residency: PGY-1, Penn State Milton S. Hershey Medical Center
Practice/Research Interests: ECMO, pulmonary hypertencion, delerium
Greene RA, Zullo AR, Mailloux CM, Berard-Collins C, Levy M, Amass T. Effect of best practice advisories on sedation protocol compliance and drug-related hazardous condition mitigation among critical care patients. Crit Care Med. 2020; 48(2):185-91.
Greene RA, Adams KK, Rogers RD, Berard-Collins C, Lorenzo MP. Pharmacokinetics of flucytosine in a critically ill patient on continuous venovenous hemodiafiltration. Am J Health Syst Pharm. 2020; 77(8):609-613.
Sorial MN, Greene RA, Zullo AR, Berard-Collins C, Willis S. Exogenous supplementation of antithrombin III in adult and pediatric patients receiving extracorporeal membrane oxygenation [published online ahead of print November 21, 2019]. Int J Artif Organs. doi: 10.1177/0391398819888932